Candriam SCA’s Medicines Co MDCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-157,106
| Closed | -$13.3M | – | 812 |
|
|
2019
Q4 | $13.3M | Sell |
157,106
-124,394
| -44% | -$8.3M | 0.14% | 166 |
|
|
2019
Q3 | $14.1M | Buy |
281,500
+60,000
| +27% | +$2.39M | 0.19% | 129 |
|
|
2019
Q2 | $8.04M | Buy |
221,500
+85,000
| +62% | +$2.77M | 0.1% | 224 |
|
|
2019
Q1 | $3.81M | Hold |
136,500
| – | – | 0.05% | 372 |
|
|
2018
Q4 | $2.61M | Hold |
136,500
| – | – | 0.04% | 407 |
|
|
2018
Q3 | $4.08M | Buy |
136,500
+26,000
| +24% | +$980K | 0.05% | 366 |
|
|
2018
Q2 | $4.06M | Buy |
110,500
+22,500
| +26% | +$731K | 0.06% | 339 |
|
|
2018
Q1 | $2.9M | Hold |
88,000
| – | – | 0.05% | 397 |
|
|
2017
Q4 | $2.41M | Sell |
88,000
-14,000
| -14% | -$431K | 0.04% | 418 |
|
|
2017
Q3 | $3.78M | Buy |
102,000
+12,000
| +13% | +$442K | 0.07% | 327 |
|
|
2017
Q2 | $3.42M | Buy |
90,000
+13,000
| +17% | +$579K | 0.06% | 346 |
|
|
2017
Q1 | $3.77M | Sell |
77,000
-26,000
| -25% | -$1.19M | 0.07% | 311 |
|
|
2016
Q4 | $3.5M | Buy |
103,000
+4,000
| +4% | +$142K | 0.08% | 272 |
|
|
2016
Q3 | $3.74M | Buy |
99,000
+24,000
| +32% | +$904K | 0.09% | 242 |
|
|
2016
Q2 | $2.52M | Hold |
75,000
| – | – | 0.07% | 274 |
|
|
2016
Q1 | $2.37M | Buy |
75,000
+11,700
| +18% | +$382K | 0.06% | 297 |
|
|
2015
Q4 | $2.36M | Hold |
63,300
| – | – | 0.06% | 274 |
|
|
2015
Q3 | $2.4M | Sell |
63,300
-16,700
| -21% | -$586K | 0.06% | 311 |
|
|
2015
Q2 | $2.29M | Sell |
80,000
-35,000
| -30% | -$975K | 0.05% | 341 |
|
|
2015
Q1 | $3.22M | Buy |
115,000
+40,000
| +53% | +$1.12M | 0.06% | 324 |
|
|
2014
Q4 | $2.08M | Buy |
+75,000
| New | +$1.86M | 0.04% | 352 |
|
Other funds holding MDCO
Candriam SCA's MDCO Position: Q1 2020 in Review
Candriam SCA sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 157,106 shares — an estimated $13.3M sold.
Candriam SCA first reported a position in MDCO in Q4 2014 and held it in 21 quarters. The position peaked at $14.1M in Q3 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.
- Candriam SCA reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
- Candriam SCA sold 157,106 Medicines Co shares in Q1 2020, an estimated $13.3M.
- Candriam SCA first reported a position in Medicines Co in Q4 2014 and held it in 21 quarters.
- Candriam SCA's Medicines Co position peaked at $14.1M in Q3 2019.
- 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.
Based on Candriam SCA's 13F filing for Q1 2020, filed 26 May 2020.